Rapid scientific progress brings new understandings of the nature of the structure-functional relationships involved in biology and disease states. Dedicated scientists, with the help of state-of-the-art technology, are accelerating the progression of drug candidates to new medicines that prevent disease, provide cures and protect the quality of life.

At Aderis, our scientists are committed to leveraging small molecule technology based on receptor subtype selectivity to develop treatments that help people with devastating diseases live more normal lives - and experience fewer side-effects. Our scientists bring their own expertise in biology, pharmacology and synthetic chemistry to the task of developing small molecule therapies.

Here you can begin to learn more about how we develop new medicines, our platform research programs, and the core competences that allow us to put our knowledge to practical use.